Key facts
- This page summarizes Tao Levy's Form 4 filing for MASIMO CORP (MASI).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 15 Nov 2024, 18:05.
Tao Levy - 13 Nov 2024 Form 4 Insider Report for MASIMO CORP (MASI)
- Reporting relationship
- EVP, Bus Dev
- Issuer ticker
- MASI
- Reported as of
- 13 Nov 2024
- Net transaction value
- -$2,327,869
- SEC form
- 4
- Accepted by SEC
- 15 Nov 2024, 18:05:19 UTC
- Prior SEC filing
- 01 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Micah W. Young, Attorney-In-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Tao Levy filed Form 4 for MASIMO CORP (MASI) on 15 Nov 2024.
Change
- Previous filing in this sequence was filed on 01 Mar 2024.
- Current net transaction value: -$2,327,869.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MASI
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +30,000
- Change %
- +268%
- Price
- $0.000000
- Shares after
- 41,208
- Date
- 13 Nov 2024
- Ownership
- Direct
MASI
transaction
Common Stock
Tax liability
- Transaction value
- $2,327,869
- Shares
- -14,398
- Change %
- -35%
- Price
- $161.68
- Shares after
- 26,810
- Date
- 13 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MASI
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -30,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 13 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,000
- Exercise price
- Footnotes
- F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain performance restricted stock units.
Footnote F2
Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock of the Issuer upon vesting of the RSU.
Footnote F3
These RSUs were granted on March 1, 2024.
Footnote F4
On November 13, 2024, in connection with its strategic shift to refocus on its core healthcare business, Masimo Corporation ("the Company") terminated the employment of Tao Levy, the Company's Executive Vice President, Business Development. 100% of the unvested RSUs vested in full upon Mr. Levy's covered termination, as defined by the Masimo Corporation 2017 Equity Incentive Plan Restricted Stock Unit Award Agreement.